Claus is a serial entrepreneur in the Life Sciences with 20 years expertise in the Industry. He co-founded Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) in 2001 and was CFO up to the listing of the Company in the US playing a key role in transforming Pieris to its current stage. He also served as CEO of Pieris executing its first international pharma partnerships.
Furthermore, Claus is co-founder and CEO of XL-protein GmbH since 2009 leading the Company to profitability by executing a series of collaborations with Pharma and Biotech.
Claus began his career with Arthur Andersen and subsequently served as CEO for companies within the IT industry. He holds a Master of Business Administration from the University of Bamberg, Germany.